Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00168285
Status:
UNKNOWN
Last Update Posted:
2007-04-05
First Post:
2005-09-13
Brief Title:
Pulmonary Rehabilitation in Interstitial Lung Disease
Sponsor:
The Alfred
Organization:
The Alfred
Study Overview
Official Title:
Pulmonary Rehabilitation in Interstitial Lung Disease - a Multi-Centre Single-Blinded Randomised Controlled Trial
Status:
UNKNOWN
Status Verified Date:
2007-04
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Interstitial lung disease ILD is a highly disabling group of conditions including idiopathic pulmonary fibrosis IPF acute and chronic interstitial pneumonias connective tissue diseases and sarcoidosis People with ILD frequently experience breathlessness on exertion which limits their ability to undertake daily activities People with ILD report very poor quality of life due to low levels of physical functioning and vitality and high levels of breathlessness and fatigue There are few treatments for ILD and those that are available have limited impact on quality of life
The aim of this study is to assess the effects of Pulmonary Rehabilitation which consists of specialised exercise training for people with lung disease on exercise capacity and quality of life in people with ILD We hypothesis that exercise training will result in reduced dyspnoea improved exercise tolerance and enhanced quality of life
The aim of this study is to assess the effects of Pulmonary Rehabilitation which consists of specialised exercise training for people with lung disease on exercise capacity and quality of life in people with ILD We hypothesis that exercise training will result in reduced dyspnoea improved exercise tolerance and enhanced quality of life
Detailed Description:
Interstitial lung disease ILD is a highly disabling group of conditions including idiopathic pulmonary fibrosis IPF acute and chronic interstitial pneumonias connective tissue diseases and sarcoidosis People with ILD frequently experience breathlessness on exertion which limits their ability to undertake daily activities and reduces health-related quality of lifeAvailable treatments for ILD have proved largely ineffective offering no improvement in survival and demonstrating only limited impact on quality of life
Aims of the Research
1 Evaluate the effects of Pulmonary Rehabilitation on exercise capacity and quality of life in patients with ILD
2 Determine the physiological response to Pulmonary Rehabilitation in patients with ILD
3 Determine the relationship between the aetiology and severity of ILD and the effects of Pulmonary Rehabilitation
Comparisons 8 weeks exercise training compared to control group maximal exercise capacity functional exercise capacity dyspnoea quality of life
Aims of the Research
1 Evaluate the effects of Pulmonary Rehabilitation on exercise capacity and quality of life in patients with ILD
2 Determine the physiological response to Pulmonary Rehabilitation in patients with ILD
3 Determine the relationship between the aetiology and severity of ILD and the effects of Pulmonary Rehabilitation
Comparisons 8 weeks exercise training compared to control group maximal exercise capacity functional exercise capacity dyspnoea quality of life
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None